Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01244 3D MEDICINES
RT Nominal down3.550 -0.020 (-0.560%)
Latest  |  Final  |  Interim
Non-current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others121,733-8.654%133,266126,82252,24610,864
Land & other Lease Assets25,992-56.668%59,98451,02166,29315,937
Intangible Assets625-14.030%7278289290
Interests in Asso. & JCEs0--0000
Other Non-current Assets80,155-42.644%139,75110,33421,5987,660

228,505-31.530%333,728189,005141,06634,461
Current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories4,059-11.990%4,6121,196130
Trade Receivables47,862776.754%5,45978,04165,0040
Cash & Bank Balances444,318-33.333%666,472696,740774,306414,261
Other Current Assets491,51217.415%418,611367,08179,90447,494
Assets Held for Sale0--0000

987,751-9.807%1,095,1541,143,058919,227461,755
Current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables51,131-28.885%71,89915,8803,7422,416
S-T Debt & Leases212,866-5.224%224,599115,30112,7547,313
Other Current Liabilities223,7919.770%203,873245,0683,231,549305,279
Liab asso w/ Assets Held for Sale0--0000

487,788-2.515%500,371376,2493,248,045315,008
Net Current Assets499,963-15.942%594,783766,809(2,328,818)146,747
Total Assets Less Current Liabilities728,468-21.544%928,511955,814(2,187,752)181,208
Non-current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases24,754-57.192%57,82660,40045,98713,061
Other Non-current Liabilities0--0038,8231,437,962

24,754-57.192%57,82660,40084,8101,451,023
Capital and Reserves
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital2260.000%2262235737
  Reserves784,836-16.196%936,513942,778(2,238,068)(1,269,852)
  Others0--0000
Shareholders' Funds785,062-16.192%936,739943,001(2,238,011)(1,269,815)
Non-controlling Interests(81,348)23.154%(66,054)(47,587)(34,551)0
Others0--0000

703,714-19.177%870,685895,414(2,272,562)(1,269,815)
Commitments and Contingent Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----77,77280,802126,2600
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 22/04/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -182,663,000
%Change-65.187%
EPS / (LPS)RMB -0.750
NBV Per Share (¥)RMB 3.040
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.